Creative Biolabs

Creative Biolabs, headquartered in New York, is a leading custom service provider in the field of vaccine development, preclinical assessment and GMP manufacturing. Our technical and regulatory experts can provide vaccine developers with a full range of products and vaccine related services. We combine traditional and the most updated genetic engineering technologies to efficiently produce highly immunogenic and safe vaccines to address emergency unmet medical needs.

Our service portfolio includes a full range of vaccine design for your specific requirements that covers vaccine target validation, vaccines targeting bacterial, viral, fungal, parasites, cancer markers and more. We also provide formulation optimization services for maximum potency, including improving delivery systems, a great variety of adjuvant products and services like PRR Ligands scanning and adjuvants synthesis. In addition, Creative Biolabs assist vaccine researchers and manufacturers with vaccine analytics service and in vitro and in vivo preclinical assessment to evaluate the safety, potency and quality of your vaccines. We also partner with multiple commercial cGMP facilities and cGMP-manufacturing which enable large scale vaccine production.

Creative Biolabs was founded by scientists who are dedicated to the development of vaccines and other immunotherapies. We believe to build up a custom-service-centered business model is crucial for optimizing the vaccine development process, leveraging accessible resources, and gathering a team from various backgrounds to conduct vaccine development projects in the future. Our commitment to this long-term goal motivates us to deliver the highest quality results to our clients and accelerate the pace of technology evolvement.